Ioannis S Vizirianakis

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 43

Top Venues

Pharmaceutics

Molecules (Basel, Switzerland)

Pharmaceuticals (Basel, Switzerland)

Chemical communications (Cambridge, England)

Aristotle University of Thessaloniki

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Aristotle University of Thessaloniki Mar 11 1982

Greece

Associate Professor :: School of Pharmacy

Publications

Paraskevi-Kyriaki Monou, Eleftherios G Andriotis, Eirini Saropoulou, Emmanouil Tzimtzimis, Dimitrios Tzetzis, Georgios Komis, Chrysanthi Bekiari, Nikolaos Bouropoulos, Efterpi Demiri, Ioannis S Vizirianakis, Dimitrios G Fatouros
Fabrication of Hybrid Coated Microneedles with Donepezil Utilizing Digital Light Processing and Semisolid Extrusion Printing for the Management of Alzheimer's Disease. Molecular pharmaceutics (2024)
Paraskevi-Kyriaki Monou, Eleftherios G Andriotis, Eirini Saropoulou, Emmanouil Tzimtzimis, Dimitrios Tzetzis, Georgios Komis, Chrysanthi Bekiari, Nikolaos Bouropoulos, Efterpi Demiri, Ioannis S Vizirianakis, Dimitrios G Fatouros
Fabrication of Hybrid Coated Microneedles with Donepezil Utilizing Digital Light Processing and Semisolid Extrusion Printing for the Management of Alzheimer's Disease. Molecular pharmaceutics 21 (9) (2024)
Paraskevi Kyriaki Monou, Eleftherios Andriotis, Dimitrios Tzetzis, Emmanouil Tzimtzimis, Emmanuel Panteris, Dimitrios Andreadis, Efterpi Demiri, Ioannis S Vizirianakis, Dimitrios G Fatouros
Evaluation of 3D-Printed Solid Microneedles Coated with Electrosprayed Polymeric Nanoparticles for Simultaneous Delivery of Rivastigmine and N-Acetyl Cysteine. ACS applied bio materials 7 (5) (2024)
Paraskevi Kyriaki Monou, Eleftherios Andriotis, Dimitrios Tzetzis, Emmanouil Tzimtzimis, Emmanuel Panteris, Dimitrios Andreadis, Efterpi Demiri, Ioannis S Vizirianakis, Dimitrios G Fatouros
Evaluation of 3D-Printed Solid Microneedles Coated with Electrosprayed Polymeric Nanoparticles for Simultaneous Delivery of Rivastigmine and N-Acetyl Cysteine. ACS applied bio materials (2024)
Paraskevi Kyriaki Monou, Eleftherios Andriotis, Dimitrios Tzetzis, Emmanouil Tzimtzimis, Emmanuel Panteris, Dimitrios Andreadis, Efterpi Demiri, Ioannis S Vizirianakis, Dimitrios G Fatouros
Evaluation of 3D-Printed Solid Microneedles Coated with Electrosprayed Polymeric Nanoparticles for Simultaneous Delivery of Rivastigmine and N-Acetyl Cysteine. ACS applied bio materials 7 (5) (2024)
Aliki Papadimitriou-Tsantarliotou, Chrysostomos Avgeros, Maria Konstantinidou, Ioannis S Vizirianakis
Analyzing the role of ferroptosis in ribosome-related bone marrow failure disorders: From pathophysiology to potential pharmacological exploitation. IUBMB life (2024)
Androulla N Miliotou, Parthena F Foltopoulou, Alexandra Ingendoh-Tsakmakidis, Asterios S Tsiftsoglou, Ioannis S Vizirianakis, Ioannis S Pappas, Lefkothea C Papadopoulou
Protein Transduction Domain-Mediated Delivery of Recombinant Proteins and In Vitro Transcribed mRNAs for Protein Replacement Therapy of Human Severe Genetic Mitochondrial Disorders: The Case of Sco2 Deficiency. Pharmaceutics 15 (1) (2023)
Androulla N Miliotou, Parthena F Foltopoulou, Alexandra Ingendoh-Tsakmakidis, Asterios S Tsiftsoglou, Ioannis S Vizirianakis, Ioannis S Pappas, Lefkothea C Papadopoulou
Protein Transduction Domain-Mediated Delivery of Recombinant Proteins and In Vitro Transcribed mRNAs for Protein Replacement Therapy of Human Severe Genetic Mitochondrial Disorders: The Case of Sco2 Deficiency. Pharmaceutics 15 (1) (2023)
Petrou Anthi, Geronikaki Athina, Victor Kartsev, Antonios Kousaxidis, Aliki Papadimitriou-Tsantarliotou, Marina Kostić, Marija Ivanov, Marina D Soković, Ioannis Nicolaou, Ioannis S Vizirianakis
N -Derivatives of ( Z )-Methyl 3-(4-Oxo-2-thioxothiazolidin-5-ylidene)methyl)-1 H -indole-2-carboxylates as Antimicrobial Agents-In Silico and In Vitro Evaluation. Pharmaceuticals (Basel, Switzerland) 16 (1) (2023)
Georgios Angelis, Georgios Sant, Ioannis S Vizirianakis, Georgios Pampalakis
Growth of chemical gardens in gaseous acidic atmospheres. Chemical communications (Cambridge, England) (2023)
Georgios Angelis, Georgios Sant, Ioannis S Vizirianakis, Georgios Pampalakis
Growth of chemical gardens in gaseous acidic atmospheres. Chemical communications (Cambridge, England) 59 (11) (2023)
Michelyne Haroun, Maria Fesatidou, Petrou Anthi, Christophe Tratrat, Panagiotis Zagaliotis, Antonis Gavalas, Katharigatta Narayanaswamy Venugopala, Hafedh Kochkar, Promise Madu Emeka, Nancy S Younis, Dalia Ahmed Elmaghraby, Mervt M Almostafa, Muhammad Shahzad Chohan, Ioannis S Vizirianakis, Aliki Papadimitriou-Tsantarliotou, Geronikaki Athina
Identification of Novel Cyclooxygenase-1 Selective Inhibitors of Thiadiazole-Based Scaffold as Potent Anti-Inflammatory Agents with Safety Gastric and Cytotoxic Profile. Molecules (Basel, Switzerland) 28 (8) (2023)
Theofanis Vavilis, Eleni Stamoula, Alexandra Ainatzoglou, Athanasios Sachinidis, Malamatenia Lamprinou, Ioannis Dardalas, Ioannis S Vizirianakis
mRNA in the Context of Protein Replacement Therapy. Pharmaceutics 15 (1) (2023)
Michelyne Haroun, Maria Fesatidou, Petrou Anthi, Christophe Tratrat, Panagiotis Zagaliotis, Antonis Gavalas, Katharigatta Narayanaswamy Venugopala, Hafedh Kochkar, Promise Madu Emeka, Nancy S Younis, Dalia Ahmed Elmaghraby, Mervt M Almostafa, Muhammad Shahzad Chohan, Ioannis S Vizirianakis, Aliki Papadimitriou-Tsantarliotou, Geronikaki Athina
Identification of Novel Cyclooxygenase-1 Selective Inhibitors of Thiadiazole-Based Scaffold as Potent Anti-Inflammatory Agents with Safety Gastric and Cytotoxic Profile. Molecules (Basel, Switzerland) 28 (8) (2023)
Petrou Anthi, Geronikaki Athina, Victor Kartsev, Antonios Kousaxidis, Aliki Papadimitriou-Tsantarliotou, Marina Kostić, Marija Ivanov, Marina D Soković, Ioannis Nicolaou, Ioannis S Vizirianakis
N -Derivatives of ( Z )-Methyl 3-(4-Oxo-2-thioxothiazolidin-5-ylidene)methyl)-1 H -indole-2-carboxylates as Antimicrobial Agents-In Silico and In Vitro Evaluation. Pharmaceuticals (Basel, Switzerland) 16 (1) (2023)
Petrou Anthi, Geronikaki Athina, Victor Kartsev, Antonios Kousaxidis, Aliki Papadimitriou-Tsantarliotou, Marina Kostić, Marija Ivanov, Marina D Soković, Ioannis Nicolaou, Ioannis S Vizirianakis
N -Derivatives of ( Z )-Methyl 3-(4-Oxo-2-thioxothiazolidin-5-ylidene)methyl)-1 H -indole-2-carboxylates as Antimicrobial Agents-In Silico and In Vitro Evaluation. Pharmaceuticals (Basel, Switzerland) 16 (1) (2023)
Theofanis Vavilis, Eleni Stamoula, Alexandra Ainatzoglou, Athanasios Sachinidis, Malamatenia Lamprinou, Ioannis Dardalas, Ioannis S Vizirianakis
mRNA in the Context of Protein Replacement Therapy. Pharmaceutics 15 (1) (2023)
Androulla N Miliotou, Parthena F Foltopoulou, Alexandra Ingendoh-Tsakmakidis, Asterios S Tsiftsoglou, Ioannis S Vizirianakis, Ioannis S Pappas, Lefkothea C Papadopoulou
Protein Transduction Domain-Mediated Delivery of Recombinant Proteins and In Vitro Transcribed mRNAs for Protein Replacement Therapy of Human Severe Genetic Mitochondrial Disorders: The Case of Sco2 Deficiency. Pharmaceutics 15 (1) (2023)
Petrou Anthi, Geronikaki Athina, Victor Kartsev, Antonios Kousaxidis, Aliki Papadimitriou-Tsantarliotou, Marina Kostić, Marija Ivanov, Marina D Soković, Ioannis Nicolaou, Ioannis S Vizirianakis
N -Derivatives of ( Z )-Methyl 3-(4-Oxo-2-thioxothiazolidin-5-ylidene)methyl)-1 H -indole-2-carboxylates as Antimicrobial Agents-In Silico and In Vitro Evaluation. Pharmaceuticals (Basel, Switzerland) 16 (1) (2023)
Maria Ganopoulou, Theodoros Moysiadis, Anastasios Gounaris, Nikolaos Mittas, Fani Chatzopoulou, Dimitrios Chatzidimitriou, Georgios Sianos, Ioannis S Vizirianakis, Lefteris Angelis
Single Nucleotide Polymorphisms' Causal Structure Robustness within Coronary Artery Disease Patients. Biology 12 (5) (2023)
Michelyne Haroun, Maria Fesatidou, Petrou Anthi, Christophe Tratrat, Panagiotis Zagaliotis, Antonis Gavalas, Katharigatta Narayanaswamy Venugopala, Hafedh Kochkar, Promise Madu Emeka, Nancy S Younis, Dalia Ahmed Elmaghraby, Mervt M Almostafa, Muhammad Shahzad Chohan, Ioannis S Vizirianakis, Aliki Papadimitriou-Tsantarliotou, Geronikaki Athina
Identification of Novel Cyclooxygenase-1 Selective Inhibitors of Thiadiazole-Based Scaffold as Potent Anti-Inflammatory Agents with Safety Gastric and Cytotoxic Profile. Molecules (Basel, Switzerland) 28 (8) (2023)
Georgios Angelis, Georgios Sant, Ioannis S Vizirianakis, Georgios Pampalakis
Growth of chemical gardens in gaseous acidic atmospheres. Chemical communications (Cambridge, England) 59 (11) (2023)
Theofanis Vavilis, Eleni Stamoula, Alexandra Ainatzoglou, Athanasios Sachinidis, Malamatenia Lamprinou, Ioannis Dardalas, Ioannis S Vizirianakis
mRNA in the Context of Protein Replacement Therapy. Pharmaceutics 15 (1) (2023)
Paraskevi Kyriaki Monou, Eleftherios G Andriotis, Konstantinos Tsongas, Emmanouil K Tzimtzimis, Orestis L Katsamenis, Dimitrios Tzetzis, Pinelopi Anastasiadou, Christos Ritzoulis, Ioannis S Vizirianakis, Dimitrios Andreadis, Dimitrios G Fatouros
Fabrication of 3D Printed Hollow Microneedles by Digital Light Processing for the Buccal Delivery of Actives. ACS biomaterials science & engineering (2023)
Michelyne Haroun, Maria Fesatidou, Petrou Anthi, Christophe Tratrat, Panagiotis Zagaliotis, Antonis Gavalas, Katharigatta Narayanaswamy Venugopala, Hafedh Kochkar, Promise Madu Emeka, Nancy S Younis, Dalia Ahmed Elmaghraby, Mervt M Almostafa, Muhammad Shahzad Chohan, Ioannis S Vizirianakis, Aliki Papadimitriou-Tsantarliotou, Geronikaki Athina
Identification of Novel Cyclooxygenase-1 Selective Inhibitors of Thiadiazole-Based Scaffold as Potent Anti-Inflammatory Agents with Safety Gastric and Cytotoxic Profile. Molecules (Basel, Switzerland) 28 (8) (2023)
Theofanis Vavilis, Eleni Stamoula, Alexandra Ainatzoglou, Athanasios Sachinidis, Malamatenia Lamprinou, Ioannis Dardalas, Ioannis S Vizirianakis
mRNA in the Context of Protein Replacement Therapy. Pharmaceutics 15 (1) (2023)
Eleftheria Galatou, Elena Mourelatou, Sophia Hatziantoniou, Ioannis S Vizirianakis
Nonalcoholic Steatohepatitis (NASH) and Atherosclerosis: Explaining Their Pathophysiology, Association and the Role of Incretin-Based Drugs. Antioxidants (Basel, Switzerland) 11 (6) (2022)
Paraskevi-Kyriaki Monou, Anastasia Maria Mamaligka, Emmanuil K Tzimtzimis, Dimitrios Tzetzis, Souzan Vergkizi-Nikolakaki, Ioannis S Vizirianakis, Eleftherios G Andriotis, Georgios K Eleftheriadis, Dimitrios G Fatouros
Fabrication and Preliminary In Vitro Evaluation of 3D-Printed Alginate Films with Cannabidiol (CBD) and Cannabigerol (CBG) Nanoparticles for Potential Wound-Healing Applications. Pharmaceutics 14 (8) (2022)
Christophe Tratrat, Petrou Anthi, Geronikaki Athina, Marija Ivanov, Marina Kostić, Marina D Soković, Ioannis S Vizirianakis, Nikoleta F Theodoroula, Michelyne Haroun
Thiazolidin-4-Ones as Potential Antimicrobial Agents: Experimental and In Silico Evaluation. Molecules (Basel, Switzerland) 27 (6) (2022)
Volodymyr Horishny, Geronikaki Athina, Victor Kartsev, Vasyl Matiychuk, Petrou Anthi, Pavel V Pogodin, Vladimir V Poroikov, Theodora A Papadopoulou, Ioannis S Vizirianakis, Marina Kostic, Marija Ivanov, Marina D Soković
Synthesis, Biological Evaluation and Molecular Docking Studies of 5-Indolylmethylen-4-oxo-2-thioxothiazolidine Derivatives. Molecules (Basel, Switzerland) 27 (3) (2022)
Fani Chatzopoulou, Konstantinos A Kyritsis, Christos I Papagiannopoulos, Eleftheria Galatou, Nikolaos Mittas, Nikoleta F Theodoroula, Αndreas S Papazoglou, Efstratios Karagiannidis, Maria Chatzidimitriou, Anna Papa, Georgios Sianos, Lefteris Angelis, Dimitrios Chatzidimitriou, Ioannis S Vizirianakis
Dissecting miRNA-Gene Networks to Map Clinical Utility Roads of Pharmacogenomics-Guided Therapeutic Decisions in Cardiovascular Precision Medicine. Cells 11 (4) (2022)
George A Mystridis, Georgios C Batzias, Ioannis S Vizirianakis
Physiologically Based Pharmacokinetic Modelling and Simulation to Predict the Plasma Concentration Profile of Doxorubicin. Pharmaceutics 14 (3) (2022)
Petrou Anthi, Panagiotis Zagaliotis, Nikoleta F Theodoroula, George A Mystridis, Ioannis S Vizirianakis, Thomas J Walsh, Geronikaki Athina
Thiazole/Thiadiazole/Benzothiazole Based Thiazolidin-4-One Derivatives as Potential Inhibitors of Main Protease of SARS-CoV-2. Molecules (Basel, Switzerland) 27 (7) (2022)
Nikoleta F Theodoroula, Christina Karavasili, Manos C Vlasiou, Alexandra Primikyri, Christia Nicolaou, Alexandra V Chatzikonstantinou, Aikaterini-Theodora Chatzitaki, Christos C Petrou, Nicolaos Bouropoulos, Constantinos K K Zacharis, Eleftheria Galatou, Yiannis Sarigiannis, Dimitrios G Fatouros, Ioannis S Vizirianakis
NGIWY-Amide: A Bioinspired Ultrashort Self-Assembled Peptide Gelator for Local Drug Delivery Applications. Pharmaceutics 14 (1) (2022)
Panagiotis Zagaliotis, Petrou Anthi, George A Mystridis, Geronikaki Athina, Ioannis S Vizirianakis, Thomas J Walsh
Developing New Treatments for COVID-19 through Dual-Action Antiviral/Anti-Inflammatory Small Molecules and Physiologically Based Pharmacokinetic Modeling. International journal of molecular sciences 23 (14) (2022)
Sergei Simakov, Victor Kartsev, Petrou Anthi, Ioannis Nicolaou, Geronikaki Athina, Marija Ivanov, Marina Kostic, Jasmina Glamočlija, Marina D Soković, Despoina Talea, Ioannis S Vizirianakis
4-(Indol-3-yl)thiazole-2-amines and 4-ιndol-3-yl)thiazole Acylamines as Νovel Antimicrobial Agents: Synthesis, In Silico and In Vitro Evaluation. Pharmaceuticals (Basel, Switzerland) 14 (11) (2021)
Ioannis S Vizirianakis, Fani Chatzopoulou, Andreas S Papazoglou, Efstratios Karagiannidis, Georgios Sofidis, Nikolaos Stalikas, Christos Stefopoulos, Konstantinos A Kyritsis, Nikolaos Mittas, Nikoleta F Theodoroula, Aggeliki Lampri, Eleni Mezarli, Anastasios Kartas, Dimitrios Chatzidimitriou, Anna Papa-Konidari, Eleftherios Angelis, Ηaralambos Karvounis, Georgios Sianos
The GEnetic Syntax Score: a genetic risk assessment implementation tool grading the complexity of coronary artery disease-rationale and design of the GESS study. BMC cardiovascular disorders 21 (1) (2021)
Christos I Papagiannopoulos, Nikoleta F Theodoroula, Konstantinos A Kyritsis, Melpomeni G Akrivou, Maria Kosmidou, Konstantina Tsouderou, Nikolaos Grigoriadis, Ioannis S Vizirianakis
The histone methyltransferase inhibitor A-366 enhances hemoglobin expression in erythroleukemia cells upon co-exposure with chemical inducers in culture. Journal of biological research (Thessalonike, Greece) 28 (1) (2021)
Theodora Christoforidou, Dimitra Giasafaki, Eleftherios G Andriotis, Nicolaos Bouropoulos, Nikoleta F Theodoroula, Ioannis S Vizirianakis, Theodore A Steriotis, Georgia Charalambopoulou, Dimitrios G Fatouros
Oral Drug Delivery Systems Based on Ordered Mesoporous Silica Nanoparticles for Modulating the Release of Aprepitant. International journal of molecular sciences 22 (4) (2021)
Christos I Papagiannopoulos, Nikoleta F Theodoroula, Ioannis S Vizirianakis
miR-16-5p Promotes Erythroid Maturation of Erythroleukemia Cells by Regulating Ribosome Biogenesis. Pharmaceuticals (Basel, Switzerland) 14 (2) (2021)
Ioannis S Vizirianakis, Fani Chatzopoulou, Andreas S Papazoglou, Efstratios Karagiannidis, Georgios Sofdis, Nikolaos Stalikas, Christos Stefopoulos, Konstantinos A Kyritsis, Nikolaos Mittas, Nikoleta F Theodoroula, Aggeliki Lampri, Eleni Mezarli, Anastasios Kartas, Dimitrios Chatzidimitriou, Anna Papa-Konidari, Eleftherios Angelis, Ηaralambos Karvounis, Georgios Sianos
Correction to: The GEnetic Syntax Score: a genetic risk assessment implementation tool grading the complexity of coronary artery disease-rationale and design of the GESS study. BMC cardiovascular disorders 21 (1) (2021)
Eleni Kontogiannidou, Thomas Meikopoulos, Helen G Gika, Emmanuel Panteris, Ioannis S Vizirianakis, Anette Müllertz, Dimitrios G Fatouros
In Vitro Evaluation of Self-Nano-Emulsifying Drug Delivery Systems (SNEDDS) Containing Room Temperature Ionic Liquids (RTILs) for the Oral Delivery of Amphotericin B. Pharmaceutics 12 (8) (2020)
Lefki-Pavlina N Giassafaki, Scheyla Siqueira, Emmanuel Panteris, Konstantina Psatha, Fani Chatzopoulou, Michalis Aivaliotis, Georgios Tzimagiorgis, Anette Müllertz, Dimitrios G Fatouros, Ioannis S Vizirianakis
Towards analyzing the potential of exosomes to deliver microRNA therapeutics. Journal of cellular physiology 236 (2) (2020)

Ioannis S Vizirianakis.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Ioannis S Vizirianakis